Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 7, 2022
Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy
Michael P Coleman
Methods in Molecular Biology (Clifton, N.J.)
|
June 12, 2020
Axon Degeneration: Which Method to Choose?
Michael P Coleman
Experimental Neurology
|
June 18, 2013
The challenges of axon survival: introduction to the special issue on axonal degeneration
Michael P Coleman
Plos Biology
|
February 4, 2010
Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons
Jonathan Gilley, Michael P Coleman
Nature Reviews. Neuroscience
|
March 11, 2020
Programmed axon degeneration: from mouse to mechanism to medicine
Michael P Coleman, Ahmet Höke
Journal of Molecular Neuroscience : MN
|
October 30, 2014
The axon-protective WLD(S) protein partially rescues mitochondrial respiration and glycolysis after axonal injury
Katharina Godzik, Michael P Coleman
The Journal of Biological Chemistry
|
October 2, 2014
Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2)
Stefan Milde, Michael P Coleman
Annual Review of Neuroscience
|
March 30, 2010
Wallerian degeneration, wld(s), and nmnat
Michael P Coleman, Marc R Freeman
Trends in Neurosciences
|
September 11, 2002
Axon pathology in neurological disease: a neglected therapeutic target
Michael P Coleman, V Hugh Perry
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 1, 2021
Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases
Peter Arthur-Farraj, Michael P Coleman
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 7, 2022
Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy
Michael P Coleman
Methods in Molecular Biology (Clifton, N.J.)
|
June 12, 2020
Axon Degeneration: Which Method to Choose?
Michael P Coleman
Experimental Neurology
|
June 18, 2013
The challenges of axon survival: introduction to the special issue on axonal degeneration
Michael P Coleman
Plos Biology
|
February 4, 2010
Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons
Jonathan Gilley, Michael P Coleman
Nature Reviews. Neuroscience
|
March 11, 2020
Programmed axon degeneration: from mouse to mechanism to medicine
Michael P Coleman, Ahmet Höke
Journal of Molecular Neuroscience : MN
|
October 30, 2014
The axon-protective WLD(S) protein partially rescues mitochondrial respiration and glycolysis after axonal injury
Katharina Godzik, Michael P Coleman
The Journal of Biological Chemistry
|
October 2, 2014
Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2)
Stefan Milde, Michael P Coleman
Annual Review of Neuroscience
|
March 30, 2010
Wallerian degeneration, wld(s), and nmnat
Michael P Coleman, Marc R Freeman
Trends in Neurosciences
|
September 11, 2002
Axon pathology in neurological disease: a neglected therapeutic target
Michael P Coleman, V Hugh Perry
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 1, 2021
Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases
Peter Arthur-Farraj, Michael P Coleman
Page
of 11